Fundraising Fox

Scholar Rock Holding Corp, Inc.

NASDAQ: SRRK

Cambridge, US · Founded 2017 · Delaware corporation · 3 known investors

Clinical-stage biopharmaceutical company focused on discovery and development of innovative medicines for serious diseases by targeting the Transforming Growth Factor Beta pathway.

Biotech

Founders & leadership

AB
Alan BucklerExecutive Officer
NM
Nagesh MahanthappaExecutive Officer, Director
TS
Timothy SpringerDirector
DH
David HallalDirector
MG
Michael GilmanDirector
JF
Jeffrey FlierDirector
YH
Yung H. ChyungExecutive Officer
EZ
Elan Z. EzicksonExecutive Officer
AN
Amir NashatDirector
KB
Kristina BurowDirector

Investors · 3

Samsara BioCapitalPalo Alto
ARCH Venture PartnersreportedChicago · $50K – $250Mvia Kristina Burow · board
Polaris PartnersreportedBoston · $500K – $5Mvia Amir Nashat · board

Reported raises · per SEC filings

Form D private placements
▶$47MraisedJan 2018 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Amir NashatDirector
  • Alan BucklerExecutive Officer
  • Kristina BurowDirector
  • Nagesh MahanthappaExecutive Officer, Director
  • Timothy SpringerDirector
  • David HallalDirector
  • Michael GilmanDirector
  • Jeffrey FlierDirector
  • Yung H. ChyungExecutive Officer
  • Elan Z. EzicksonExecutive Officer
Offering amount
$47M
Amount sold
$47M
First sale
Dec 2017
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.